Saratoga Health & Biotechnology C (SHPCX)
| Fund Assets | 10.10M |
| Expense Ratio | 3.32% |
| Min. Investment | $250 |
| Turnover | 17.00% |
| Dividend (ttm) | 0.25 |
| Dividend Yield | 1.88% |
| Dividend Growth | -75.16% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 10, 2024 |
| Previous Close | 13.53 |
| YTD Return | 7.36% |
| 1-Year Return | -1.22% |
| 5-Year Return | 29.99% |
| 52-Week Low | 12.06 |
| 52-Week High | 14.42 |
| Beta (5Y) | n/a |
| Holdings | 29 |
| Inception Date | Jan 18, 2000 |
About SHPCX
Saratoga Health & Biotechnology Portfolio Fund Class C is a sector-focused mutual fund that primarily invests in the healthcare and biotechnology industries. Its main objective is the preservation and appreciation of capital through diversified holdings across U.S. and, to a lesser extent, foreign companies engaged in pharmaceuticals, medical devices, biotechnology, healthcare services, and related sub-sectors. Managed by Oak Associates LTD, the fund employs a top-down investment approach, targeting long-term economic trends to identify high-quality companies with strong fundamentals and growth potential within the healthcare sector. The portfolio is actively managed, with a significant allocation to large- and mid-cap companies but also includes exposure to small and micro-cap firms. This fund is designed for investors seeking specialized exposure to the evolving healthcare and biotech landscapes, sectors that play a vital role in advancing global health solutions and medical innovation. Saratoga Health & Biotechnology Portfolio Fund Class C stands out by focusing on industries with long-term growth prospects driven by demographic shifts, technological advancement, and rising healthcare needs.
Performance
SHPCX had a total return of -1.22% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.87%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Top 10 Holdings
48.91% of assets| Name | Symbol | Weight |
|---|---|---|
| Amgen Inc. | AMGN | 5.82% |
| Cencora, Inc. | COR | 5.66% |
| McKesson Corporation | MCK | 5.62% |
| Cardinal Health, Inc. | CAH | 5.18% |
| Novartis AG ADR | NVSN.MX | 4.80% |
| Exelixis, Inc. | EXEL | 4.70% |
| Dreyfus Institutional Reserves Funds - Dreyfus Institutional Preferred Government Money Market Fund | DSVXX | 4.42% |
| United Therapeutics Corporation | UTHR | 4.33% |
| Jazz Pharmaceuticals plc | JAZZ | 4.20% |
| The Cigna Group | CI | 4.19% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 10, 2024 | $0.2534 | Dec 11, 2024 |
| Dec 8, 2023 | $1.0202 | Dec 11, 2023 |
| Dec 9, 2022 | $1.2749 | Dec 12, 2022 |
| Dec 10, 2021 | $0.7883 | Dec 13, 2021 |
| Dec 11, 2020 | $2.5794 | Dec 11, 2020 |
| Dec 11, 2019 | $0.9077 | Dec 11, 2019 |